AzTrials
AzTrials

InfertilityAMH FSH AFCNCT02173444

Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response

A study testing Blood test in people with Infertility, run by Vietnam National University at 1 site in Vietnam.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Serum bio-markers have different prediction values for ovarian response during ovarian stimulation in-vitro fertilization Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Infertility
What is being tested?
Blood test
How many people
820 participants
Where
1 siteVietnam
Study dates
Jan 2013to Oct 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age ≤ 45 years at the time of FSH starting
  • BMI < 25 kg/m2,
  • First IVF attempt
  • Receiving GnRH-antagonist protocol
  • Had oocyte retrieval

Who cannot join

  • Had ovarian stimulation or ovulation induction within 2 months prior to the study
  • PCOS
  • Had ovarian tumor or endometrioma
  • Hyperprolactinemia
  • Thyroid hormone disorders
  • Pituitary failure
  • Had other medical situations such as liver failure, renal failure, heart disease, diabetes, depression
  • Had IVM

Trial locations and contacts

1 site in 1 country.

Vietnam1 site
  • An Sinh Hospital

    Ho Chi Minh City, Ho Chi Minh

Other trials in Vietnam

About this study

Serum bio-markers have different prediction values for ovarian response during ovarian stimulation in-vitro fertilization

Conditions
Infertility
Being tested
Blood test
Keywords
in-vitro fertilization, ovarian stimulation
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood testOther

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of oocytes

    Measured: At the time of oocyte retrieval

  2. number of oocytes at time of oocyte retrieval

    Measured: up to 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2014 (estimated)
  2. Study startJan 2013
  3. Primary completionOct 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
820 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02173444
Sponsor's protocol ID
1234-DHYD
Acronym
AMH FSH AFC
Status last verified
Jun 2014
First submitted
23 Jun 2014
Last updated
25 Jun 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Blood test in people with Infertility, run by Vietnam National University at 1 site in Vietnam.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of oocytes (time frame: At the time of oocyte retrieval). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2014; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in